CRISPR/Cas9 screens identify key host factors that enhance rotavirus reverse genetics efficacy and vaccine production
Yinxing Zhu,
Meagan E. Sullender,
Danielle E. Campbell,
Leran Wang,
Sanghyun Lee,
Takahiro Kawagishi,
Gaopeng Hou,
Alen Dizdarevic,
Philippe H. Jais,
Megan T. Baldridge,
Siyuan Ding
Affiliations
Yinxing Zhu
Department of Molecular Microbiology, Washington University School of Medicine
Meagan E. Sullender
Department of Medicine, Division of Infectious Diseases and Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine
Danielle E. Campbell
Department of Medicine, Division of Infectious Diseases and Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine
Leran Wang
Department of Medicine, Division of Infectious Diseases and Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine
Sanghyun Lee
Division of Biology and Medicine, Department of Molecular Microbiology and Immunology, Brown University
Takahiro Kawagishi
Department of Molecular Microbiology, Washington University School of Medicine
Gaopeng Hou
Department of Molecular Microbiology, Washington University School of Medicine
Alen Dizdarevic
Department of Molecular Microbiology, Washington University School of Medicine
Philippe H. Jais
Eukarÿs SAS, Pépinière Genopole, 4 rue Pierre Fontaine, Genopole Entreprises Campus 3, 4 Rue Pierre Fontaine 91000
Megan T. Baldridge
Department of Molecular Microbiology, Washington University School of Medicine
Siyuan Ding
Department of Molecular Microbiology, Washington University School of Medicine
Abstract Rotaviruses pose a significant threat to young children. To identify novel pro- and anti-rotavirus host factors, we performed genome-wide CRISPR/Cas9 screens using rhesus rotavirus and African green monkey cells. Genetic deletion of either SERPINB1 or TMEM236, the top two antiviral factors, in MA104 cells increased virus titers in a rotavirus strain independent manner. Using this information, we optimized the existing rotavirus reverse genetics systems by combining SERPINB1 knockout MA104 cells with a C3P3-G3 helper plasmid. We improved the recovery efficiency and rescued several low-titer rotavirus reporter and mutant strains that prove difficult to rescue otherwise. Furthermore, we demonstrate that TMEM236 knockout in Vero cells supported higher yields of two live-attenuated rotavirus vaccine strains than the parental cell line and represents a more robust vaccine-producing cell substrate. Collectively, we developed a third-generation optimized rotavirus reverse genetics system and generated gene-edited Vero cells as a new substrate for improving rotavirus vaccine production.